story of the week
Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2: A Preliminary Report of a Phase 1/2, Single-Blind, Randomised Controlled Trial
Lancet 2020 Jul 20;[EPub Ahead of Print], PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, S Belij-Rammerstorfer, D Bellamy, S Bibi, M Bittaye, EA Clutterbuck, C Dold, SN Faust, A Finn, AL Flaxman, B Hallis, P Heath, D Jenkin, R Lazarus, R Makinson, AM Minassian, KM Pollock, M Ramasamy, H Robinson, M Snape, R Tarrant, M Voysey, C Green, AD Douglas, AVS Hill, T Lambe, SC Gilbert, AJ PollardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.